|
FULC Fulcrum Therapeutics Inc 1680581 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-18,891,000.00 |
| Balance Sheet |
|
Current Assets
|
$338,669,000.00 |
|
Assets
|
$346,770,000.00 |
|
Current Liabilities
|
$9,864,000.00 |
|
Liabilities
|
$13,467,000.00 |
|
Equity
|
$333,303,000.00 |
|
Shares Out
|
66608096.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,750,000.00 |
|
Investing Cash Flow
|
$-128,210,000.00 |
| Market Analysis |
Market Cap
|
$247,782,117.12 |
|
Price
|
$3.65 |
|
BVPS
|
5.00 |
|
PB
|
0.74 |
|
EPS
|
-0.25 |
|
FCF
|
$-18,758,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
-0.31 |
|
| Apr |
May |
Jun |
|
|
2026-04-27 |
-0.25 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-29 |
-0.28 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
-0.31 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FULC documents filed with the SEC.
FULC Filings
Clear
